Learn More
Medchemexpress LLC Terazosin hydrochloride dihydrate | 70024-40-7 | 99.5% | 1 ML

Supplier: Medchemexpress LLC HYB0371A10MM/1ML
Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive, orally active α1-adrenoceptor antagonist. It functions by relaxing blood vessels and aiding in the opening of the bladder. This compound has potential applications in the treatment of benign prostatic hyperplasia (BPH) and high blood pressure. This product is for research use only.
- Competitive α1-adrenoceptor antagonist
- Relaxes blood vessels
- Aids in opening the bladder
- Potential for treating benign prostatic hyperplasia (BPH)
- Potential for treating high blood pressure
- Does not differentiate cloned α1-adrenoceptor subtypes
- Can promote stone discharge in the treatment of ureteral stones
- Reportedly safe and effective for distal ureteral stones, especially those >5 mm
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.